“Miller & Levine Biology Digital Path Curriculum Earns ... - PRWeb” plus 3 more |
- Miller & Levine Biology Digital Path Curriculum Earns ... - PRWeb
- Sigma-Aldrich Expands In Vivo Biology Offerings through ... - Genetic Engineering News
- Biology's 'bad boy' revels in pushing boundaries - The Age
- Sigma-Aldrich Further Expands In Vivo Biology Offering ... - Forbes
Miller & Levine Biology Digital Path Curriculum Earns ... - PRWeb Posted: 16 Mar 2010 06:02 AM PDT | Online Version of Pearson's Bestselling High School Biology Program Honored in Best Science Instructional Solution Category Boston, MA (PRWEB) March 16, 2010 -- Miller & Levine Biology™ Digital Path from Pearson is a finalist in the 2010 Software & Information Industry Association (SIIA) CODiE Awards. The innovative online digital curriculum from the nation's bestselling high school biology program is a finalist in the Best Science Instructional Solution category.
Established in 1986, the CODiE Awards celebrate outstanding achievement across the software, digital information and education technology industries. The comprehensive review process of nominated products included intense scrutiny by subject matter experts, education industry analysts, journalists and specialists in the implementation of education technology. With the Miller & Levine Biology Digital Path, thousands of students across the country are taking a virtual journey and living the science experience. Named for its two internationally renowned scientist-authors, Ken Miller and Joe Levine, this innovative program takes a bold approach to science instruction, combining the power of new technology with a proven foundation of academic success. "Miller & Levine Biology Digital Path gives teachers powerful tools for personalizing learning and engaging students with multimedia learning experiences that allow them to experience what a scientist does when exploring the rainforest or studying infectious diseases," said Lynda Cloud, Pearson's Senior Vice President for Science. "Recognition as a finalist in the 2010 SIIA CODiE Awards reinforces our belief that technology can help all students learn the big ideas and concepts of this important field of science - regardless of their learning style or ability." Through Biology.com, students meet their partners on this science adventure - a team of "ecogeeks" who have created real experiences, infusing curriculum topics with a new relevance for students. Described by Levine as "science reality TV," "Untamed Science" offers the perfect blend of energy, enthusiasm and solid scientific knowledge. Biology students enjoy exploring their world as they embark on real-life science video adventures with these young and infectious "ecogeeks." The program's dynamic digital path offers students and teachers a wealth of other engaging activities and information, including complete online student and teacher editions of the textbooks, editable worksheets, interactive study guides, fun science games and online assessments. Pearson had 13 education finalists in the CODiE Awards this year, leading the prestigious competition. Pearson's innovative ed-tech solutions for schools, colleges and universities are recognized across the awards program's education categories, honoring the company's worldwide leadership in harnessing technology to personalize and improve learning. Pearson's 13 finalists were chosen from more than 327 education nominations submitted by 124 companies. In addition to Miller & Levine Biology™ Digital Path, the company's products moving on to the next round of competition are CourseConnect™, eCollege (now known as Pearson LearningStudio), Mastering Platform, MathXL® for School, MyCourse, MyMathLab, MyWritingLab, myWorld Geography™, Prentice Hall Literature Online (PHLitOnline) and PowerSchool. In the next step of the CODiE Awards process, Miller & Levine Biology™ Digital Path will now be voted on by the entire SIIA membership to determine the winners in each category. The 2010 CODiE Awards will be announced at the 2010 Ed Tech Industry Summit in San Francisco on May 24. About Pearson For more information, press only: ### Post Comment: Five Filters featured article: Chilcot Inquiry. Available tools: PDF Newspaper, Full Text RSS, Term Extraction. | |
Sigma-Aldrich Expands In Vivo Biology Offerings through ... - Genetic Engineering News Posted: 16 Mar 2010 07:21 AM PDT Mar 16 2010, 10:23 AM EST Sigma-Aldrich Expands In Vivo Biology Offerings through Purchase of Ace AnimalsGEN News Highlights Sigma-Aldrich is acquiring Ace Animals, a provider of research rodents to the biomedical industry. Ace Animals offers products and contract breeding services and will operate as part of Sigma Advanced Genetic Engineering (SAGE™) Labs. The acquisition will enhance SAGE Labs' current rat and mouse breeding capabilities, primarily used in the development and characterization of its next-generation knockout and knockin rat models featuring specific gene deletions, insertions, repressions, and modifications. These models are created using CompoZr™ Zinc Finger Nuclease technology. SAGE Labs' portfolio of products and services now includes a number of wild-type rats and mice, including Swiss Webster, Sprague Dawley, ICR, Balb/c, C57BL/6, and Cotton Rats. In addition, the fact that Ace Animals is located in Berks County, PA, is expected to enhance distribution of SAGE Labs' models to key sites within the U.S. biopharma industry. "With the Ace Animals acquisition, SAGE Labs will be in a better position to offer a greater number of models with the goal of helping researchers understand the functional significance of genes and their relationships to human diseases," comments Edward Weinstein, Ph.D., director of SAGE Labs.
♦♦♦ Comment on this News:Five Filters featured article: Chilcot Inquiry. Available tools: PDF Newspaper, Full Text RSS, Term Extraction. | ||
Biology's 'bad boy' revels in pushing boundaries - The Age Posted: 16 Mar 2010 06:02 AM PDT Genome pioneer J. Craig Venter in Melbourne. Photo: Jason South HE HAS been described as ''biology's bad boy'' but as far as renowned American scientist J. Craig Venter is concerned he is just breaking new ground. If other scientists want to follow him, as many do, then they are welcome to. As for the controversial tag that is sometimes attached to his name, he wears it as a badge of honour. ''Anybody that is pushing the forefront of science is considered controversial,'' he said in Melbourne yesterday. ''Science by nature is very conservative, but the only way you move boundaries and make new discoveries is by trying new approaches.'' Among his goals is to sequence all the genes on the planet and to be the first to create artificial life by manufacturing DNA in the laboratory. He has a track record that leaves few doubting his capability. In 1995 Dr Venter and his team decoded the genome of the first free-living organism, a bacterium called Haemophilus influenzae. In 2001 he and his team sequenced the human genome and have since sequenced the genome of the fruit fly, rat and mouse. Dr Venter has also sequenced his own DNA, one of only 12 people in the world to sequence their genome, and was the first to sequence a dog's genome - that of his pet poodle, Shadow. ''But one day there will be millions to join my club,'' he said. In Melbourne to deliver a free public lecture tonight, Dr Venter is considered a pioneer in the field of synthetic biology - where DNA is made in the laboratory, effectively creating artificial life. But ethical, moral and legal questions about public access to scientific discoveries and private profit dog his work. On the contentious issue of patenting genes - the topic of a Senate inquiry due to conclude in June - Dr Venter admits it is ''a fight over who makes money off the genome''. But he says he has no problem with the practice. ''If it leads to a new therapeutic [treatments] or helping to understand new diseases then it's worth doing,'' he said. It is the draw of the unknown that makes science so attractive to Dr Venter, who has appeared on Time magazine's list of the world's most influential people more than once. Scientists do not know how many genes there are on the planet but they have discovered well over 20 million in the past eight years. That number is rising, thanks to another project of Dr Venter's, the ''voyage of microbial discovery'' on the yacht the Sorcerer II, which is sailing the world's oceans sampling and sequencing micro-organisms. It's the new frontier - one naturalist Charles Darwin couldn't have imagined. ''It's a whole new way to look at life,'' Dr Venter said. ''Almost everything Darwin categorised was what he could see with his eyes and with crude microscopes. But we're now using the genetic code to see what's there in the invisible world, and it turns out the invisible world is far greater than the visible world.'' Dr Venter will be awarded a Doctor of Science honoris causa by Melbourne University tomorrow. Dr Venter will deliver a free public lecture tonight at the Melbourne Convention Centre. Register at www.ict4lifesciences.org.au. Five Filters featured article: Chilcot Inquiry. Available tools: PDF Newspaper, Full Text RSS, Term Extraction. | ||
Sigma-Aldrich Further Expands In Vivo Biology Offering ... - Forbes Posted: 16 Mar 2010 04:15 AM PDT ST. LOUIS, March 16 /PRNewswire-FirstCall/ -- Sigma-Aldrich(R) (Nasdaq: SIAL) today announced it has signed an agreement to acquire Ace Animals, Inc., a Berks County, PA.-based provider of high quality research rodents to the biomedical industry. Ace Animals (www.aceanimals.com), a commercial rodent breeder established in 1973, offers high quality products and contract breeding services, and will operate as part of Sigma Advanced Genetic Engineering (SAGE(TM)) Labs (www.sageresearchmodels.com), a Sigma(R) Life Science initiative. Terms and conditions of the agreement were not disclosed. Closing is expected shortly. The acquisition will enhance SAGE Labs' current rat and mouse breeding capabilities, primarily used in the development and characterization of its unique, next-generation 'Knockout' and 'Knockin' rat models featuring specific gene deletions, insertions, repressions and modifications created using proprietary CompoZr(TM) Zinc Finger Nuclease (ZFN) technology. In addition, Ace Animals' strategic location in Pennsylvania is expected to greatly enhance distribution of SAGE Labs models to key sites within the United States bio-pharma industry. Through the acquisition, SAGE Labs plans to offer a significantly increased portfolio of products and services, including a number of 'wild type' (that is, animals that have not been genetically modified) rats and mice, including Swiss Webster, Sprague Dawley, ICR, Balb/c, C57BL/6 and Cotton Rats. SAGE Labs will be positioned to offer contract breeding services, considered a natural extension of its current SAGEspeed(TM) animal creation service. Concurrently, Ace Animals, Inc.'s customers are expected to benefit from access to the industry-leading genetic engineering platforms offered through Sigma's SAGE labs. SAGE Labs is the premier resource for genetically modified rodent disease models and markets its exclusive SAGEspeed(TM) Custom Model Development program for the creation of knockout mouse or rat models in as little as five months. The group is also developing their catalog of knockout rat models across a number of research fields, including Neurobiology, Toxicology, Cardiology and Immunology. "With the Ace Animals acquisition, SAGE Labs will be in a better position to offer a greater number of models with the goal of helping researchers understand the functional significance of genes and their relationships to human diseases," said Dr. Edward Weinstein, Director of SAGE Labs. "In vivo models of human disease states serve as more predictive proxies to the human condition, and therefore are instrumental to the discovery of novel and powerful therapeutics." For more information on SAGE Labs visit www.sageresearchmodels.com. For more information on Ace Animals visit www.aceanimals.com. Cautionary statement: The foregoing release contains forward-looking statements that can be identified by terminology such as "is expected to greatly enhance," "plans to offer," "expected to benefit," "premier source," "instrumental" or similar expressions, or by express or implied discussions regarding potential future revenues from products derived therefrom. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that products will continue to meet the demands of the marketplace. Nor can there be any guarantee that any of these products will achieve any particular levels of revenue in the future. In particular, management's expectations regarding these products could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Company's assets and liabilities as recorded in its consolidated balance sheet, and other risks and factors referred to in Sigma-Aldrich's current Form 10-K on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Sigma-Aldrich is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise. About Sigma Life Science: Sigma Life Science is a Sigma-Aldrich brand that represents Sigma's leadership in innovative biological products and services for the global life science market and offers an array of biologically-rich products and reagents that researchers use in scientific investigation. Product areas include biomolecules, genomics and functional genomics, cells and cell-based assays, transgenics, protein assays, stem cell research, epigenetics and custom services/oligonucleotides. Sigma Life Science also provides an extensive range of critical bioessentials like biochemicals, antibiotics, buffers, carbohydrates, enzymes, forensic tools, hematology and histology, nucleotides, amino acids and their derivatives, and cell culture media. About SAGE Labs: SAGE Labs, a Sigma Life Science initiative, is a world-class provider of research models, including knockout rat models, and extensive support services. Using Sigma's proprietary platform technologies, SAGE specializes in genetic manipulation of in vivo systems for specialized R&D applications. SAGE Labs specializes in the development and characterization of unique, next-generation animal research models featuring specific gene deletions, insertions, repressions and modifications using proprietary CompoZr ZFN (zinc finger nuclease) technology. This genetic manipulation technology works for a variety of animal research models, as well as a wide range of research applications. About Sigma-Aldrich:Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. Sigma-Aldrich has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 38 countries and has 7,700 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning website at http://www.sigma-aldrich.com. CompoZr, SAGEspeed, SAGE, Sigma-Aldrich and Sigma are trademarks of Sigma-Aldrich Biotechnology L.P. and Sigma-Aldrich Co. SOURCE Sigma-Aldrich Copyright 2009 PR Newswire All rights reserved. Five Filters featured article: Chilcot Inquiry. Available tools: PDF Newspaper, Full Text RSS, Term Extraction. |
You are subscribed to email updates from Biology - Bing News To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google Inc., 20 West Kinzie, Chicago IL USA 60610 |
0 comments:
Post a Comment